For the quarter ending 2026-04-03, EXPO had -$103,377K decrease in cash & cash equivalents over the period. -$3,428K in free cash flow.
| Cash Flow | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 |
|---|---|---|---|---|
| Net income | 29,569 | 24,762 | 28,044 | 53,203 |
| Depreciation and amortization of property, equipment and leasehold improvements | 2,515 | 2,539 | 2,532 | 5,012 |
| Provision for contract losses and doubtful accounts | 268 | 891 | 1,511 | 586 |
| Stock-based compensation | 9,058 | 5,028 | 5,341 | 13,426 |
| Deferred income tax provision | 3,164 | -3,987 | -2,867 | -3,094 |
| Accounts receivable | 16,097 | 402 | 12,495 | 10,191 |
| Prepaid expenses and other current assets | 4,755 | -4,564 | 4,021 | -7,135 |
| Change in operating leases | -1,129 | -172 | -1,301 | -1,756 |
| Accounts payable and accrued liabilities | 6,100 | 3,714 | -189 | 4,153 |
| Accrued payroll and employee benefits | -28,626 | 12,335 | 12,246 | -23,774 |
| Deferred revenues | -3,300 | 5,966 | 1,249 | -4,716 |
| Net cash (used in) provided by operating activities | -975 | 55,582 | 32,652 | 43,496 |
| Capital expenditures | 2,453 | 2,687 | 2,675 | 4,028 |
| Net cash used in investing activities | -2,453 | -2,687 | -2,675 | -4,028 |
| Payroll taxes for restricted stock units | 5,113 | 0 | 0 | 4,166 |
| Repurchase of common stock | 78,761 | 24,383 | 40,032 | 32,680 |
| Exercise of stock-based payment awards | 777 | 866 | 595 | 911 |
| Dividends and dividend equivalents rights | 16,583 | 14,887 | 15,070 | 31,582 |
| Net cash used in financing activities | -99,680 | -38,404 | -54,507 | -67,517 |
| Effect of foreign currency exchange rates on cash and cash equivalents | -269 | 59 | 109 | 949 |
| Net decrease in cash and cash equivalents | -103,377 | 14,550 | -24,421 | -27,100 |
| Cash and cash equivalents at beginning of period | 221,930 | 207,380 | 258,901 | - |
| Cash and cash equivalents at end of period | 118,553 | 221,930 | 207,380 | - |
EXPONENT INC (EXPO)
EXPONENT INC (EXPO)